peripheral artery disease
Conditions
Interventions
Case series:Atherectomy, drug Coated balloon dilatation
Sponsors
Beijing Tsinghua Changgung Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: (1) aged between 18 and 90 years; (2) patients with peripheral artery disease (PAD) and Rutherford grade between 3 and 5; (3) de novo and/or secondary moderate-severe stenosis (?50%) or total occlusion lesions in infrainguinal artery which is TASC II type A/B/C; (4) the subject understands the trial content and signs Informed Consent Form before the start of the trial.
Exclusion criteria
Exclusion criteria: (1) patients with acute thrombosis requiring thrombolysis and thrombectomy; (2) patients with known allergic history of anti-platelet drugs, anticoagulants, contrast agents, paclitaxel and others; (3) patients who have participated in other clinical trials of drugs or other medical devices that may interfere this clinical trials within the past 3 months; (4) pregnant and lactating woman; (5) patients with bleeding tendency, coagulation dysfunction and hypercoagulability; (6) patients with other diseases that may lead to test difficulties or significantly shorten life expectancy (<2 years), tumor, liver disease, cardiac insufficiency and other diseases which cause life expectancy is less than 6 months; (7) patients who are unable or unwilling to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 12-month patency rate; | — |
Countries
China
Contacts
Public ContactWeiwei Wu
Beijing Tsinghua Changgung Hospital
Outcome results
None listed